Tingting Ni

Xuzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Retrospective Analysis of the Molecular Links Among Clustered Cases of Acinetobacter baumannii Nosocomial Infections Occurring in Different Years within the ICU - Jiangsu Province, China, 2016-2021.

Retrospective Analysis of the Molecular Links Among Clustered Cases of Acinetobacter baumannii Nosocomial Infections Occurring in Different Years within the ICU - Jiangsu Province, China, 2016-2021.

Journal: China CDC weekly
Published: October 10, 2025

Metabolic reprogramming and immune microenvironment characteristics in laryngeal carcinoma: advances in immunotherapy.

Metabolic reprogramming and immune microenvironment characteristics in laryngeal carcinoma: advances in immunotherapy.

Journal: Frontiers in immunology
Published: March 07, 2025

Expression level and clinical significance of NBAT-1 in human cancers: a systematic review and meta-analysis.

Expression level and clinical significance of NBAT-1 in human cancers: a systematic review and meta-analysis.

Journal: BMC cancer
Published: June 16, 2023

High-intensity focused ultrasound ablation combined with systemic therapy for unresectable colorectal cancer liver metastasis: A propensity score-matched analysis.

High-intensity focused ultrasound ablation combined with systemic therapy for unresectable colorectal cancer liver metastasis: A propensity score-matched analysis.

Journal: Cancer medicine
Published: April 23, 2023

Molecular typing and prognostic risk models for ovarian cancer: a study based on cell differentiation trajectory.

Molecular typing and prognostic risk models for ovarian cancer: a study based on cell differentiation trajectory.

Journal: Frontiers in cell and developmental biology
Published: December 25, 2022

Safety and efficacy of radiotherapy/chemoradiotherapy combined with immune checkpoint inhibitors for non-small cell lung cancer: A systematic review and meta-analysis.

Safety and efficacy of radiotherapy/chemoradiotherapy combined with immune checkpoint inhibitors for non-small cell lung cancer: A systematic review and meta-analysis.

Journal: Frontiers in immunology
Published: October 09, 2022

Salvage high intensity focused ultrasound for residual or recurrent cervical cancer after definitive chemoradiotherapy.

Salvage high intensity focused ultrasound for residual or recurrent cervical cancer after definitive chemoradiotherapy.

Journal: Frontiers in immunology
Published: July 16, 2022

Efficacy and safety of radiotherapy/chemoradiotherapy combined with immune checkpoint inhibitors for locally advanced stages of esophageal cancer: A systematic review and meta-analysis.

Efficacy and safety of radiotherapy/chemoradiotherapy combined with immune checkpoint inhibitors for locally advanced stages of esophageal cancer: A systematic review and meta-analysis.

Journal: Frontiers in oncology
Published: March 01, 2022

Low-dose cyclophosphamide combined with IL-2 inhibits tumor growth by decreasing regulatory T cells and increasing CD8+ T cells and natural killer cells in mice.

Low-dose cyclophosphamide combined with IL-2 inhibits tumor growth by decreasing regulatory T cells and increasing CD8+ T cells and natural killer cells in mice.

Journal: Immunobiology
Published: September 02, 2021

Identification of the Prognostic Signature Associated With Tumor Immune Microenvironment of Uterine Corpus Endometrial Carcinoma Based on Ferroptosis-Related Genes.

Identification of the Prognostic Signature Associated With Tumor Immune Microenvironment of Uterine Corpus Endometrial Carcinoma Based on Ferroptosis-Related Genes.

Journal: Frontiers in cell and developmental biology
Published: July 01, 2021

An immune-related lncRNA pairs signature to identify the prognosis and predict the immune landscape of laryngeal squamous cell carcinoma.

An immune-related lncRNA pairs signature to identify the prognosis and predict the immune landscape of laryngeal squamous cell carcinoma.

Journal: BMC cancer
Published: June 20, 2021

NLK interacts with 14‑3‑3ζ to restore the expression of E‑cadherin.

NLK interacts with 14‑3‑3ζ to restore the expression of E‑cadherin.

Journal: Oncology reports
Published: September 03, 2019
Showing 1-12 of 24

Last Updated: 09/26/2026